
Flagship’s Alltrna Trims Staff Before First Patient Dosed—Smart Risk or Red Flag?
Strategic Leaning in a Capital-Conscious Biotech Environment Flagship Pioneering’s Alltrna has made the unusual decision to trim its workforce ahead of dosing its first patient